Synthesis, characterization, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH(3))}(2)mu-{trans-Pt(NH(3))(2-hydroxypyridine)-(H(2)N(CH(2))(6)NH(2))(2)]Cl(4).

[1]  R. Ian Freshney,et al.  Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications , 2010 .

[2]  P. Beale,et al.  Studies on activities, cell up take and DNA binding of four multinuclear complexes of the form: [{trans-PtCl(NH3)2}2μ-{trans-Pd(NH3)2-(H2N(CH2)nNH2)2}]Cl4 where n = 4–7 , 2004 .

[3]  P. Beale,et al.  Synthesis, characterisation, activities, cell uptake and DNA binding of [[trans-PtCl(NH3)2] [mu-(H2N(CH2)6NH2)] [trans-PdCl(NH3)2](NO3)Cl. , 2004, European journal of medicinal chemistry.

[4]  P. Beale,et al.  Studies on the synthesis and characterization of four trans-planaramineplatinum(II) complexes of the form trans-PtL(NH3)CL2 where L = 2-hydroxypyridine, 3-hydroxypyridine, imidazole, and imidazo(1,2-α)pyridine , 2004 .

[5]  M. Fuertes,et al.  Novel Concepts in the Development of Platinum Antitumour Drugs: An Update , 2004 .

[6]  J. Collins,et al.  Multi-nuclear platinum complexes as anti-cancer drugs , 2003 .

[7]  N. Farrell,et al.  Kinetic and equilibria studies of the aquation of the trinuclear platinum phase II anticancer agent [(trans-PtCl(NH(3))(2))(2)(mu-trans-Pt(NH(3))(2)(NH(2)(CH(2))(6)NH(2))(2))](4+) (BBR3464). , 2002, Inorganic chemistry.

[8]  V. Brabec,et al.  Conformation, Recognition by High Mobility Group Domain Proteins, and Nucleotide Excision Repair of DNA Intrastrand Cross-links of Novel Antitumor Trinuclear Platinum Complex BBR3464* , 2001, The Journal of Biological Chemistry.

[9]  N. Farrell,et al.  Direct evidence for preassociation preceding covalent binding in the reaction of cis-[Pt(NH3)2(H2O)2]2+ with surface immobilized oligonucleotides. , 2001, Journal of the American Chemical Society.

[10]  M. Daidone,et al.  Activity of a trinuclear platinum complex in human ovarian cancer cell lines sensitive and resistant to cisplatin: cytotoxicity and induction and gene-specific repair of DNA lesions , 2001, British Journal of Cancer.

[11]  Ralph Rapley,et al.  The Nucleic Acid Protocols Handbook , 2000, Humana Press.

[12]  A. Khokhar,et al.  Preparation, characterization, and antitumor activity of new cisplatin analogs with homopiperazines: crystal structure of [PtII(1-methylhomopiperazine)(methylmalonato)].2H2O. , 1999, Journal of inorganic biochemistry.

[13]  N. Farrell,et al.  Comparison of cytotoxicity and cellular accumulation of polynuclear platinum complexes in L1210 murine leukemia cell lines. , 1999, Journal of inorganic biochemistry.

[14]  V. Brabec,et al.  Sequence-dependent conformational changes in DNA induced by polynuclear platinum complexes. , 1999, Journal of inorganic biochemistry.

[15]  N. Farrell,et al.  The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells. , 1999, Journal of inorganic biochemistry.

[16]  S. Lippard,et al.  Structure, Recognition, and Processing of Cisplatin-DNA Adducts. , 1999, Chemical reviews.

[17]  T. Hambley,et al.  Synthesis, Structure, Biological Activity, and DNA Binding of Platinum(II) Complexes of the Type trans-[PtCl(2)(NH(3))L] (L = Planar Nitrogen Base). Effect of L and Cis/Trans Isomerism on Sequence Specificity and Unwinding Properties Observed in Globally Platinated DNA. , 1999, Inorganic chemistry.

[18]  H. Earl,et al.  Chemotherapy for ovarian cancer--a consensus statement on standard practice. , 1998, British Journal of Cancer.

[19]  Roger S. Macomber,et al.  A Complete Introduction to Modern NMR Spectroscopy , 1997 .

[20]  Abraham Nudelman,et al.  NMR Chemical Shifts of Common Laboratory Solvents as Trace Impurities. , 1997, The Journal of organic chemistry.

[21]  N. Farrell,et al.  Selective Platination of Biologically Relevant Polyamines. Linear Coordinating Spermidine and Spermine as Amplifying Linkers in Dinuclear Platinum Complexes , 1997 .

[22]  L. Kèlland,et al.  Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines. , 1992, Cancer research.

[23]  John D. Roberts,et al.  Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action. , 1991, Cancer research.

[24]  R. Ozols,et al.  Comparative cytotoxicity of CI‐973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines , 1991, International Journal of Cancer.

[25]  B. Van Houten,et al.  Comparison of chemical reactivity, cytotoxicity, interstrand cross-linking and DNA sequence specificity of bis(platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogues. , 1990, Biochemistry.

[26]  N. Farrell,et al.  Cytotoxicity and antitumor activity of bis(platinum) complexes. A novel class of platinum complexes active in cell lines resistant to both cisplatin and 1,2-diaminocyclohexane complexes. , 1990, Journal of medicinal chemistry.

[27]  D. Bowtell,et al.  Rapid isolation of eukaryotic DNA. , 1987, Analytical biochemistry.

[28]  P. Loehrer,et al.  Drugs five years later. Cisplatin. , 1984, Annals of internal medicine.

[29]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[30]  R. Roberts,et al.  Recognition sequence of specific endonuclease BamHI from Bacillus amyloliquefaciens H , 1977, Nature.

[31]  N. Farrell.  Uses of inorganic chemistry in medicine , 2007 .

[32]  N. Farrell,et al.  Cooperative effects in long-range 1,4 DNA-DNA interstrand cross-links formed by polynuclear platinum complexes: an unexpected syn orientation of adenine bases outside the binding sites , 2002, JBIC Journal of Biological Inorganic Chemistry.

[33]  S. Elmroth,et al.  Reactions of platinum(II) complexes with a DNA hairpin, d(CGCGTTGTTCGCG): structural characterization and kinetic studies , 2000 .

[34]  S. Johnson,et al.  Recent insights into platinum drug resistance in cancer. , 1998, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[35]  Sian E. Miller,et al.  Reactions of platinum(II) anticancer drugs. Kinetics of acid hydrolysis of cis-diammine(cyclobutane-1,1-dicarboxylato)platinum(II) “Carboplatin” , 1998 .

[36]  D. Tietz.  Nucleic Acid Electrophoresis , 1998, Springer Lab Manual.

[37]  K. Nakamoto.  Infrared and Raman Spectra of Inorganic and Coordination Compounds , 1978 .